Western blot showed significant upregulation of p-STAT3/STAT3 in NCI-H1650/Gef and NCI-H1975/Gef cells, suggesting a potential role of phosphorylated activated STAT3 in gefitinib resistance in NSCLC cells (Fig. 5B). The gene discussed is STAT3; the disease is non-small cell lung carcinoma.